Acute Porphyria Drug Database

Monograph

A16AB04 - Agalsidase Beta
Not porphyrinogenic
NP

Chemical description
Enzyme

Similar drugs
Explore alternative drugs in similar therapeutic classes A16A / A16AB or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Netherlands
Fabrazyme · Fabrazyme 35 mg, poeder voor concentraat voor oplossing voor intraveneuze infusie · Fabrazyme 5 mg, poeder voor concentraat voor oplossing voor intraveneuze infusie
Belgium
Fabrazyme · Fabrazyme 35 mg sol. perf. (pdr., à diluer) i.v. flac. · Fabrazyme 5 mg sol. perf. (pdr., à diluer) i.v. flac.
United Kingdom
Fabrazyme · Fabrazyme 35mg powder for concentrate for solution for infusion vials · Fabrazyme 5mg powder for concentrate for solution for infusion vials
Denmark
Fabrazyme
Norway
Fabrazyme
Poland
Fabrazyme
Luxembourg
FABRAZYME
Iceland
Fabrazyme
Finland
Fabrazyme
Latvia
Fabrazyme
Serbia
Fabrazyme · Fabrazyme®
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙